Organization Overview
Alternative names
acetaminophen (tylenol) (1 trial)
amitriptyline (elavil) (1 trial)
aripiprazole (abilify) (1 trial)
bupropion (wellbutrin) (1 trial)
dexmedetomidine (precedex) (2 trials)
gabapentin (neurontin) (2 trials)
interferon beta-1b (betaseron) (1 trial)
lidocaine (xylocaine) (2 trials)
acetylsalicylic acid (aspirin) (3 trials)
alemtuzumab (campath) (1 trial)
cytarabine (cytosar-u) (5 trials)
dipyridamole (persantine) (1 trial)
fludarabine (fludara) (6 trials)
fluorouracil (efudex) (6 trials)
galantamine (reminyl) (1 trial)
gemcitabine (gemzar) (11 trials)
abiraterone (zytiga) (3 trials)
acitretin (soriatane) (1 trial)
aldesleukin (proleukin) (4 trials)
alefacept (Amevive) (2 trials)
allogeneic cord blood (1 trial)
allogeneic hematopoietic stem cells (Hemacord) (1 trial)
allogeneic lymphocytes (5 trials)
anastrozole (arimidex) (2 trials)
apalutamide (erleada) (1 trial)
asparaginase (elspar) (2 trials)
atezolizumab (tecentriq) (2 trials)
atorvastatin (lipitor) (2 trials)
autologous hematopoietic cell (1 trial)
autologous tumor cell vaccine (1 trial)
autologous umbilical cord blood (1 trial)
azacitidine (vidaza) (3 trials)
azithromycin (zithromax) (2 trials)
bacille calmette-guerin (1 trial)
benzyl alcohol (ulesfia) (1 trial)
bevacizumab (avastin) (8 trials)
bexarotene (targretin) (2 trials)
bicalutamide (casodex) (3 trials)
calcitriol (rocaltrol) (1 trial)
capecitabine (xeloda) (7 trials)
carboplatin (paraplatin) (13 trials)
carfilzomib (kyprolis) (3 trials)
celecoxib (celebrex) (2 trials)
cetuximab (erbitux) (3 trials)
cisplatin (platinol) (7 trials)
clarithromycin (biaxin) (1 trial)
clozapine (clozaril) (1 trial)
cyclophosphamide (cytoxan) (11 trials)
cyclosporine (sandimmune) (2 trials)
daunorubicin (cerubidine) (1 trial)
decitabine (dacogen) (2 trials)
degarelix acetate (firmagon) (1 trial)
docetaxel (taxotere) (9 trials)
doxorubicin (Doxil) (7 trials)
durvalumab (imfinzi) (1 trial)
e7 tcr transduced pbl cells (1 trial)
efalizumab (raptiva) (1 trial)
epirubicin (ellence) (2 trials)
estradiol (progynon depot) (1 trial)
estramustine (emcyt) (2 trials)
etoposide (vepesid) (4 trials)
everolimus (zortress) (2 trials)
fludeoxyglucose f-18 (1 trial)
fulvestrant (faslodex) (1 trial)
gallium citrate ga 67 (2 trials)
hemopoietic stem cell (2 trials)
hydroxychloroquine (plaquenil) (14 trials)
ibrutinib (imbruvica) (3 trials)
idarubicin (idamycin) (1 trial)
in vitro-treated peripheral blood stem cell (2 trials)
ipilimumab (yervoy) (4 trials)
irinotecan (Camptosar) (5 trials)
irradiated donor lymphocyte (2 trials)
isotretinoin (accutane) (4 trials)
lenalidomide (revlimid) (7 trials)
leuprolide (lupron) (2 trials)
licorice root extract (1 trial)
mercaptopurine (purinethol) (1 trial)
mitomycin (mutamycin) (1 trial)
mitoxantrone (novantrone) (1 trial)
monoclonal antibody cd19 (1 trial)
monoclonal antibody cd20 (1 trial)
mycophenolate (myfortic) (2 trials)
nifedipine (procardia) (1 trial)
nitazoxanide (alinia) (1 trial)
nortriptyline (aventyl) (1 trial)
osimertinib (tagrisso) (1 trial)
paclitaxel (taxol) (15 trials)
pamidronate (aredia) (1 trial)
pembrolizumab (keytruda) (8 trials)
peripheral blood hematopoietic cell (3 trials)
pomalidomide (pomalyst) (1 trial)
rituximab (rituxan) (7 trials)
sargramostim (leukine) (6 trials)
sirolimus (rapamune) (2 trials)
sitagliptin (januvia) (1 trial)
sorafenib (nexavar) (4 trials)
tacrolimus (prograf) (1 trial)
talimogene laherparepvec (Imlygic) (2 trials)
temozolomide (temodar) (1 trial)
tetradecanoylphorbol acetate (2 trials)
thalidomide (Thalomid) (1 trial)
topotecan (hycamtin) (1 trial)
trastuzumab (herceptin) (1 trial)
trifluridine (viroptic) (1 trial)
trisalicylate choline (3 trials)
trivirus specific ctls for ebv, cmv and adenovirus infection (1 trial)
umbilical cord mesenchymal stem cells (1 trial)
vandetanib (caprelsa) (1 trial)
venetoclax (venclexta) (4 trials)
vincristine (oncovin) (1 trial)
besifloxacin (besivance) (1 trial)
cmv-specific t-cells (1 trial)
colchicine (colbenemid) (1 trial)
epinephrine (levophed) (1 trial)
fowlpox-sargramostim (1 trial)
immune globulin (human) (1 trial)
loratadine (claritin) (1 trial)
albendazole (Albenza) (1 trial)
carbon dioxide (dry ice) (2 trials)
COVID-19 convalescent plasma (1 trial)
dextromethorphan (delsym) (2 trials)
granisetron (kytril) (1 trial)
inactivated influenza vaccine (1 trial)
ivermectin (stromectol) (1 trial)
lactobacillus rhamnosus (2 trials)
levobupivacaine (chirocaine) (1 trial)
Acquired Immunodeficiency Syndrome (Phase 2)
Adenocarcinoma (Phase 2)
Adenocarcinoma, Mucinous (Phase 2)
Adenocarcinoma, Papillary (Phase 2)
Adenoviridae Infections (Phase 2)
Aggression (Phase 2)
Anemia (Phase 4)
Anemia, Sickle Cell (Phase 3)
Angina, Unstable (Phase 3)
Anxiety Disorders (Phase 4)
Autism Spectrum Disorder (Phase 2)
Autistic Disorder (Phase 3)
beta-Thalassemia (Phase 2)
Blast Crisis (Phase 2)
Blood Coagulation Disorders (Phase 3)
Bone Marrow Diseases (Phase 1)
Breast Neoplasms (Phase 3)
Breast Neoplasms, Male (Phase 1)
Burkitt Lymphoma (Phase 2)
Carcinoma (Phase 2)
Carcinoma, Acinar Cell (Phase 1)
Carcinoma, Adenoid Cystic (Phase 2)
Carcinoma, Basal Cell (Phase 2)
Carcinoma, Basosquamous (Phase 2)
Carcinoma, Hepatocellular (Phase 2)
Carcinoma, Merkel Cell (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Ovarian Epithelial (Phase 2)
Carcinoma, Renal Cell (Phase 2)
Carcinoma, Signet Ring Cell (Phase 2)
Carcinoma, Skin Appendage (Phase 2)
Carcinoma, Squamous Cell (Phase 2)
Carcinoma, Transitional Cell (Phase 1)
Cardiovascular Diseases (Phase 3)
Cataract (Phase 1)
Cholangiocarcinoma (Phase 2)
Colonic Neoplasms (Phase 3)
Colorectal Neoplasms (Phase 2)
Communicable Diseases (Phase 2)
Coronary Artery Disease (Phase 3)
Coronary Disease (Phase 3)
Coronavirus Infections (Phase 2)
Critical Illness (Phase 2)
Cytomegalovirus Retinitis (Phase 3)
Death, Sudden (Phase 3)
Death, Sudden, Cardiac (Phase 3)
Depression (Phase 4)
Depressive Disorder (Phase 2)
Dermatitis (Phase 2)
Dermatitis, Atopic (Phase 2)
Developmental Disabilities (Phase 2)
Diabetic Retinopathy (Phase 1)
Disease (Phase 4)
Disease Progression (Phase 1)
Down Syndrome (Phase 3)
Eczema (Phase 2)
Endometrial Neoplasms (Phase 1)
Endotoxemia (Phase 1)
Epstein-Barr Virus Infections (Phase 2)
Fatigue (Phase 4)
Fatigue Syndrome, Chronic (Phase 4)
Fibromyalgia (Phase 4)
Gallbladder Diseases (Phase 4)
Gallbladder Neoplasms (Phase 2)
Genomic Instability (Phase 2)
Glioblastoma (Phase 2)
Gout (Phase 4)
Graft vs Host Disease (Phase 2)
Headache (Phase 4)
Headache Disorders (Phase 4)
Heart Diseases (Phase 3)
Hematologic Diseases (Phase 3)
Hemorrhage (Phase 3)
Hemostatic Disorders (Phase 3)
HIV Infections (Phase 2)
Hodgkin Disease (Phase 3)
Hyperglycemia (Phase 3)
Hypertension (Phase 3)
Hypertension, Portal (Phase 3)
Immunoblastic Lymphadenopathy (Phase 2)
Infarction (Phase 3)
Infections (Phase 2)
Infertility (Phase 4)
Inflammation (Phase 1)
Inflammatory Breast Neoplasms (Phase 2)
Intraocular Lymphoma (Phase 2)
Ischemia (Phase 3)
Joint Diseases (Phase 4)
Keratoacanthoma (Phase 2)
Kidney Neoplasms (Phase 2)
Klatskin Tumor (Phase 2)
Leukemia (Phase 3)
Leukemia, Erythroblastic, Acute (Phase 2)
Leukemia, Hairy Cell (Phase 2)
Leukemia, Large Granular Lymphocytic (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Lymphoid (Phase 3)
Leukemia-Lymphoma, Adult T-Cell (Phase 2)
Leukemia, Megakaryoblastic, Acute (Phase 2)
Leukemia, Monocytic, Acute (Phase 2)
Leukemia, Myeloid (Phase 3)
Leukemia, Myeloid, Accelerated Phase (Phase 2)
Leukemia, Myeloid, Acute (Phase 3)
Leukemia, Myelomonocytic, Acute (Phase 2)
Leukemia, Myelomonocytic, Chronic (Phase 2)
Leukemia, Myelomonocytic, Juvenile (Phase 2)
Leukemia, T-Cell (Phase 2)
Leukemoid Reaction (Phase 3)
Lice Infestations (Phase 2)
Liver Neoplasms (Phase 2)
Lung Neoplasms (Phase 2)
Lymphoma (Phase 2)
Lymphoma, B-Cell (Phase 2)
Lymphoma, B-Cell, Marginal Zone (Phase 2)
Lymphoma, Extranodal NK-T-Cell (Phase 2)
Lymphoma, Follicular (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Lymphoma, Large-Cell, Anaplastic (Phase 2)
Lymphoma, Large-Cell, Immunoblastic (Phase 2)
Lymphoma, Mantle-Cell (Phase 2)
Lymphoma, Non-Hodgkin (Phase 2)
Lymphoma, T-Cell (Phase 2)
Lymphoma, T-Cell, Cutaneous (Phase 2)
Lymphoma, T-Cell, Peripheral (Phase 2)
Lymphomatoid Granulomatosis (Phase 2)
Lymphoproliferative Disorders (Phase 2)
Melanoma (Phase 3)
Metaplasia (Phase 3)
Migraine Disorders (Phase 4)
Mouth Neoplasms (Phase 1)
Multiple Myeloma (Phase 3)
Myalgia (Phase 4)
Mycoses (Phase 2)
Mycosis Fungoides (Phase 2)
Myelodysplastic Syndromes (Phase 3)
Myeloproliferative Disorders (Phase 3)
Myocardial Infarction (Phase 3)
Myocardial Ischemia (Phase 3)
Myofascial Pain Syndromes (Phase 4)
Nausea (Phase 4)
Neoplasm Metastasis (Phase 2)
Neoplasm, Residual (Phase 2)
Neoplasms (Phase 3)
Neoplasms, Glandular and Epithelial (Phase 2)
Neoplasms, Plasma Cell (Phase 3)
Neoplasms, Unknown Primary (Phase 2)
Osteoarthritis (Phase 4)
Osteoarthritis, Hip (Phase 4)
Ovarian Neoplasms (Phase 2)
Pancreatic Neoplasms (Phase 3)
Papilloma (Phase 2)
Parkinson Disease (Phase 3)
Phobia, Social (Phase 4)
Plasmablastic Lymphoma (Phase 2)
Plasmacytoma (Phase 1)
Pneumonia (Phase 3)
Precancerous Conditions (Phase 2)
Prediabetic State (Phase 2)
Preleukemia (Phase 2)
Prostatic Intraepithelial Neoplasia (Phase 2)
Prostatic Neoplasms (Phase 2)
Protein Deficiency (Phase 2)
Psoriasis (Phase 2)
Psychotic Disorders (Phase 4)
Puberty, Precocious (Phase 3)
Recurrence (Phase 2)
Reperfusion Injury (Phase 4)
Retinal Detachment (Phase 4)
Retinal Diseases (Phase 1)
Retinitis (Phase 3)
Schizophrenia (Phase 4)
Self-Injurious Behavior (Phase 2)
Severe Acute Respiratory Syndrome (Phase 2)
Sezary Syndrome (Phase 2)
Skin Neoplasms (Phase 2)
Small Cell Lung Carcinoma (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Stomach Neoplasms (Phase 2)
Stroke (Phase 3)
Sweat Gland Neoplasms (Phase 2)
Syndrome (Phase 4)
Thalassemia (Phase 2)
Thromboembolism (Phase 3)
Thymoma (Phase 2)
Thymus Neoplasms (Phase 2)
Tobacco Use Disorder (Phase 4)
Triple Negative Breast Neoplasms (Phase 2)
Urinary Bladder Neoplasms (Phase 2)
Uterine Cervical Neoplasms (Phase 2)
Ventricular Fibrillation (Phase 3)
Vitiligo (Phase 3)
Vomiting (Phase 4)
Waldenstrom Macroglobulinemia (Phase 2)